Does REZAFUNGIN Cause Off label use? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Off label use have been filed in association with REZAFUNGIN (REZZAYO). This represents 44.4% of all adverse event reports for REZAFUNGIN.
48
Reports of Off label use with REZAFUNGIN
44.4%
of all REZAFUNGIN reports
2
Deaths
3
Hospitalizations
How Dangerous Is Off label use From REZAFUNGIN?
Of the 48 reports, 2 (4.2%) resulted in death, 3 (6.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REZAFUNGIN. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does REZAFUNGIN Cause?
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which REZAFUNGIN Alternatives Have Lower Off label use Risk?
REZAFUNGIN vs RIBASPHERE
REZAFUNGIN vs RIBAVIRIN
REZAFUNGIN vs RIBOCICLIB
REZAFUNGIN vs RIBOFLAVIN
REZAFUNGIN vs RIBOFLAVIN 5'-PHOSPHATE